DUVIPHAR
ActiveSummary
DUVIPHAR has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,663 and a net result of €49,077. Equity has been growing by about 15% per year since 2018. Its solvency ranks better than 23% of 22,773 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 23-09-2010 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.192.324.813 7340 Colfontaine, since 07-10-2010
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2025
Board and ownership
- DUFRASNE Vincent Emile AlbertDirector · since 23-09-2020
- Holdings
- Shares in 2 companies PHARMACIE DU QUESNOY and TRICHERES PHARMA
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- €100,405
- ▲ 5.3%
- Turnover
- ≈ €320,000
- estimated
- Profit
- €49,077
- ▼ 12.6%
- Equity
- €15,663
- Total assets
- €1.8m
- ▲ 15.8%
- 2025 accounts filed 25 days after the deadline
Score breakdownraises riskEquity €15,663 (0.9% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: total assets €1.8mFounded in 2010Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 20% of them on solvency, 17% on liquidity, 48% on profitability and 95% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 49 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Merger: DUVIPHAR takes over PHARMACIE DU QUESNOYDissolution of the company
- · Gazette deed Merger: DUVIPHAR takes over TRICHERES PHARMADissolution of the company
- · Gazette deed Merger proposal: DUVIPHAR takes over TRICHERES PHARMA
Comparable companies
These companies have the same main activity as DUVIPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.5m and €1.9m, founded between 2004 and 2012.
| Company | Total assets | Gross margin |
|---|---|---|
| DUVIPHAR Colfontaine | €1.8m | €0.1m |
| ANTARES INVEST Celles (lez-Tournai) | €1.8m | €0.1m |
| SikaCare Hasselt | €1.8m | €0.1m |
| APOLEX Wichelen | €1.5m | €0.1m |
| Apotheek Gevaert Waregem | €1.8m | €0.1m |
| DE-PHARMA Mons | €1.6m | €0.08m |
| EXTRAPHARM TILFF Esneux | €1.9m | €0.1m |
Key facts about DUVIPHAR
- What is the company number of DUVIPHAR?
- The company number of DUVIPHAR is 0829.596.062. The VAT number is the same number with BE in front: BE 0829.596.062.
- Where is DUVIPHAR based?
- The registered office is at Rue de Pâturages 38, 7340 Colfontaine.Company details
- What does DUVIPHAR do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of DUVIPHAR?
- The legal form of DUVIPHAR is Private limited company (BV).
- When was DUVIPHAR founded?
- DUVIPHAR was founded on 23-09-2010.
- Is DUVIPHAR still active?
- Yes, DUVIPHAR is an active enterprise in the KBO register.
- What is the turnover of DUVIPHAR?
- The turnover in financial year 2025 is ≈ €320,000. This figure is estimated from the gross margin of €100,405 and 32 comparable companies (NACE 477). It probably lies between €220,000 and €620,000.Financials
- Is DUVIPHAR profitable?
- In financial year 2025, DUVIPHAR made a profit of €49,077.
- Where can I find the annual accounts of DUVIPHAR?
- DUVIPHAR filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DUVIPHAR due?
- DUVIPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.